SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

iBio Reports Q1 Fiscal Year 2027 Financial Results and Provides Corporate Update

Presented additional preclinical data supporting IBIO-610’s potential to drive fat selective weight

IBIO

Related stories